Covenant Partners LLC lessened its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 29.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 11,704 shares of the company’s stock after selling 4,926 shares during the quarter. Covenant Partners LLC’s holdings in AstraZeneca were worth $788,000 as of […]
Pin Oak Investment Advisors Inc. boosted its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 468.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 449 shares of the company’s stock after purchasing an additional 370 shares during the […]
Pin Oak Investment Advisors Inc. lifted its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 468.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 449 shares of the company’s stock after acquiring an additional 370 shares during the period. Pin Oak […]
Epoch Investment Partners Inc. raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,819,965 shares of the company’s stock after acquiring an additional 103,229 shares during the quarter. AstraZeneca accounts […]
AstraZeneca PLC (NASDAQ:AZN – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $79.47 and last traded at $79.26, with a volume of 2884431 shares trading hands. The stock had previously closed at $78.02. Analyst Upgrades and Downgrades AZN has been the subject of a […]